APPLICATION OF A VALIDATED STABILITY-INDICATING HPTLC METHOD FOR SIMULTANEOUS QUANTITATIVE DETERMINATION OF CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE IN PHARMACEUTICAL DOSAGE FORM
Keywords:
Candesartan cilexetil, hydrochlorothiazide, HPTLC, Stability indicating methodAbstract
Objective: To develop and validate stability indicating HPTLC method for simultaneous quantitative determination of candesartan cilexetil (CDT) and hydrochlorothiazide (HCT) in pharmaceutical dosage form.
Methods: The present study deals with development and validation of stability indicating HPTLC method for simultaneous estimation of CDT and HCT. Chromatographic separation was performed on aluminum plate precoated with Silica Gel 60 F254 using toluene: chloroform: ethanol: glacial acetic acid (2:7:1:0.1 v/v) as mobile phase. The wavelength selected for densitometry scanning was 270 nm. Regression plots revealed linear relationships in the concentration range of 500-5000 and 400-2000 ng/band for CDT and HCT respectively. The correlation coefficient of calibration curves was found to be more than 0.99 for both analytes.
Results: The chromatographic conditions gave compact spots at Rf value (±SD) 0.12 (±0.01) and 0.70 (±0.02) for HCT and CDT respectively. The method was validated as per International Conference on Harmonization (ICH) guidelines, demonstrating to be accurate and precise within the corresponding linearity range of titled analytes. Inherent stability of these drugs was studied by exposing drug substances to various stress conditions as per ICH guidelines namely oxidative, photolysis and hydrolytic conditions under different pH. Relevant degradation was found to take place under these conditions.
Conclusion: A new simple, accurate, precise, sensitive and economic stability-indicating HPTLC method has been developed and validated for the simultaneous determination of CDT and HCT in pharmaceutical dosage form. The proposed method can be used for the routine estimation of CDT and HCT in bulk and formulation and can be employed for stability-indicating analysis.
Keywords: Candesartan cilexetil, Hydrochlorothiazide, HPTLC, Stability indicating method, Forced degradation, Stress studies, Validation
Downloads
References
Cutler SJ. Drugs acting on the renal system. In: Beale JM, Block JH. Wilson and gisvold’s textbook of organic medicinal and pharmaceutical chemistry. 12th ed. New Delhi: Wolters Kluwer (India) Pvt. Ltd; 2011. p. 612-5.
Harvison PJ, Rankin GO. Diuretics. In: Lemke TL, Williams DA, Roche VF, Zito SW. editor. Foye’s principle of medicinal chemistry. 7th ed. New Delhi: Wolters Kluwer (India) Pvt. Ltd; 2013. p. 735-7.
Gunda S, Kakumani KK, Gangaram VK, Vishnu P, Mukkanti KA. Stability indicating UPLC method for candesartan in bulk drug samples. Am J Anal Chem 2012;3:704-9.
Manjulutha YB, Gawarisankar B. Stability indicating RP-HPLC method for the determination of candesartan in pure and pharmaceutical formulation. Int J Pharm Industrial Res 2011;1:344-9.
Kumar NDA, Sudhakar BK, Gosada U, Sharma N. A validated ultra high-pressure liquid chromatography method for separation of candesartan cilexetil impurities and its degradants in drug product. Pharm Methods 2012;3:31–9.
Bhagwate S, Gaikwad NJ, Tarte P. Stability indicating HPLC method for the determination of candesartan in pharmaceutical dosages form. Int J Pharm Sci Res 2013;4:1079-85.
Reddy AR, Kumar GVS, Puranik SB, Giriprasad P, Sridhar KA. Development and validation of stability indicating reverse phase HPLC method for simultaneous estimation of irbesartan and hydrochlorothiazide in bulk drug and tablet dosage form. Int J Pharm Chem Biosci 2012;2:696-703.
Eranki RJV, Inti G, Jayaraman V, Vidiyala SR, Jadi S. New stability indicating method for quantification of impurities in amlodipine and hydrochlorothiazide tablets by validated HPLC. Int J Pharm Res Scholars 2014;3:591-601,
Jain PS, Patel MK, Gorle AP, Chaudhari AJ, Surana SJ. A stability-indicating method for simultaneous estimation of olmesartan medoxomile, amlodipine besylate and hydrochlorothiazide by RP-HPLC in tablet dosage form. J Chrom Sci 2012;50:680-7.
Kaliappan I, Pushpangadhan S, Kumar S. Application of a stability indicating HPTLC method for simultaneous quantitative determination of olmesartan medoxomil and hydrochlorothiazide in pharmaceutical dosage forms. J Anal Methods Chem 2013;1-8. Doi.org/10.1155/2013/363741. [Article in Press]
Singha S, Patel KB, Agrawala VK, Chaturvedia S. Stability indicating HPTLC method for simultaneous determination of valsartan and hydrochlorothiazide in tablets. Int J Pharm Pharm Sci 2012;4:468-71.
Solanki TB, Shah PA, Patel KG. Central composite design for validation of HPTLC Method for simultaneous estimation of olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide in tablets. Indian J Pharm Sci 2014;76:179-87.
Shah NJ, Suhagia BN, Shah RR, Patel NM. HPTLC method for the simultaneous estimation of valsartan and hydrochlorothiazide in tablet dosage form. Indian J Pharm Sci 2009;71:72-4.
Muralikrishna C, Rambabu C. Determination of candesartan cilexetil in bulk and pharmaceutical dosage forms by visible spectrophotometric methods. Int J Sci Res 2015;4:492-5.
Annapurnaa MM, Narendra AB, Kumar KRB. Liquid chromatographic method for the simultaneous quantitative determination of candesartan cilexetil and hydrochlorthiazide in pharmaceutical dosage forms. J Drug Delivery Ther 2012;2:48-54.
Mehta BH, Morge SB. HPTLC-densitometric analysis of candesartan cilexetil and hydrochlorothiazide in tablets. J Planar Chromatogr Mod TLC 2008;21:173-6.
Youssefa RM, Mahera HM, Hassana EM, El-Kimarya EI, Bararya MA. Development and validation of HPTLC and spectrophotometric methods for simultaneous determination of candesartan cilexetil and hydrochlorothiazide in pharmaceutical preparation. Int J Appl Chem 2010;6:233-46.
Bharathi DV, Hotha KK, Chatki PK, Satyanarayana V, Venkateswarlu V. LC–MS/MS method for simultaneous estimation of candesartan and hydrochlorothiazide in human plasma and its use in clinical pharmacokinetics. Bioanal 2012;4:1195-204.
Brushinina OS, Gurto RV, Maksim ST, Frelikh GA, Slepichev VA, Yanovskaya EA, et al. Determination of candesartan and hydrochlorothiazide in human plasma by HPLC coupled with mass spectrometry. Int J Anal Mass Spectrom Chromatogr 2014; 2:25-32.
Veeranjaneyulu D, Aneesha A, Agarwal N. Stability indicating RP-HPLC method for the simultaneous determination of candesartan cilexetil and hydrochlorothiazide in bulk and dosage forms. Indian J Res Pharm Biotechnol 2013;1:720-4.
Rama JVE, Gopichand I, Venkatasubramanian J, Sudhakar RV, Sree JR. New stability indicating method for quantification of impurities in candesartan cilexetil and hydrochlorothiazide tablets by validated HPLC. Int J Pharm Res Scholars 2014;3:100-12.
Sethi PD. HPTLC: quantitative analysis of pharmaceutical formulations. 1sted. New Delhi: CBS Publishers and Distributors; 2013. p. 15-60.
Bakshi M, Singh S. Development of validated stability-indicating assay methods—critical review. J Pharm Biomed Anal 2002;28:1011–40.
International conference on harmonization, Stability testing of new drug substances and products (revision 2) Q1A (R2). Geneva: IFPMA; 2003. Available from: http://www.ich.org/ fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1A_R2/Step4/Q1A_R2__Guideline.pdf. [Last accessed on 25 Dec 2015].
International conference on harmonization, Photostability Testing of New Active Substances and Medicinal Products, Q1B, Geneva: IFPMA; 1998. Available from: http://www.ich.org/ fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1B/Step4/Q1B_Guideline.pdf. [Last accessed on 25 Dec 2015].
International conference on harmonization, Validation of Analytical Procedures: Text and Methodology Q2 (R1). Geneva: IFPMA; 2005. Available from: http://www.ich.org/ fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.Pdf. [Last accessed on 25 Dec 2015].
Huber L. Validation of analytical methods and processes. In: Nash RA, Wachter AH. editor. Pharmaceutical Process Validation. 3rd ed. New York: Marcel Dekker, Inc.; 2003. p. 542-59.
Ferenczi Fodor K, Végh Z, Nagy Turák A, Renger B, Zeller M. Validation and quality assurance of planar chromatographic procedures in pharmaceutical analysis. J AOAC Int 2001;84:1265-76.